sameAs
Fetal anemia, thrombocytopenia, dilated umbilical vein, and cardiomegaly due to a voluminous placental chorioangioma. A case report.Effects of latent toxoplasmosis on autoimmune thyroid diseases in pregnancyVaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.Performance of Droplet Digital PCR in Non-Invasive Fetal RHD Genotyping - Comparison with a Routine Real-Time PCR Based ApproachEmbryo-fetal toxicity signals for 17alpha-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins.Post-mortem magnetic resonance imaging and its irreplaceable role in determining CNS malformation (hydranencephaly)--case report.An elevated blood glucose level and increased incidence of gestational diabetes mellitus in pregnant women with latent toxoplasmosis.The influence of latent toxoplasmosis on women's reproductive function: four cross-sectional studies.Two neuroactive steroids in midpregnancy as measured in maternal and fetal sera and in amniotic fluid.Safety signals of 17-OHP-C use in pregnancy and efficacy in the prevention of preterm birth.Differentially expressed miRNAs in trisomy 21 placentas.Can the final sonographic assessment of the cesarean section scar be predicted 6 weeks after the operation?Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP).New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia.ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis.Activity of the antioxidant enzymes superoxide dismutase and glutathione peroxidase in fetal erythrocytes.Comparison of right ventricular measurements and SFRV in fetuses with and without tricuspid regurgitation at 11+0 and 13+6 weeks' gestation.FGFR2 gene mutation (Tyr375Cys) in a new case of Beare-Stevenson syndromeQuantification of circulating fetal DNA as a tool for potential monitoring of pregnant patients with antiphospholipid antibodiesCell-Free Fetal DNA in Maternal Plasma during Physiological Single Male Pregnancies: Methodology Issues and KineticsCirculating regulatory T-cells as a pregnancy marker of immunological testing for predicting adverse pregnancy outcomes: A preliminary studyA case of an epignathus with intracranial extension appearing as a persistently open mouth at 16 weeks and subsequently diagnosed at 20 weeks of gestationPrenatal detection of trisomy 21 on nucleated red blood cells enriched from maternal circulation by using fluorescencein situ hybridizationCounseling for non-invasive prenatal testing (NIPT): what pregnant women may want to knowUnderstanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): A survey of European health-care providersEvidence for linkage of nonsyndromic cleft lip with or without cleft palate to a region on chromosome 2ABO Fetomaternal Compatibility Poses a Risk for Massive Fetomaternal Transplacental HemorrhageABO fetomaternal compatibility poses a risk for massive fetomaternal transplacental hemorrhageActivities of mitochondrial oxidative phosphorylation enzymes in cultured amniocytesPlasma cysteine concentrations in uncomplicated pregnanciesPrenatally diagnosable differences in the cellular immunity of fetuses with Down's and Edwards' syndromeThe sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patientsPrenatal diagnosis of occipital dermal sinus associated with hemangioma using ultrasound and MRI. Case reportLeft ventricle shortening fraction: a comparison between euploid and trisomy 21 fetuses in the first trimesterPrenatal diagnosis of hydrometrocolpos in a Down syndrome fetusSirenomelia apus after trimethoprim exposure: first-trimester ultrasound diagnosis-a case reportShortening fraction of the right ventricle: a comparison between euploid and trisomy 21 fetuses at week 11 to week 13 and 6 days of gestationMonitoring and treatment of anti-D in pregnancy
P50
Q33343639-8C1D1048-51CD-41F5-8251-F2245A8FFBA6Q34414626-1467C5B8-2CB3-4B49-9550-09050E78854DQ34694463-BB248D0A-C7F2-45A5-80C5-78CF850E8364Q34694480-49182A9A-E84B-4543-9376-2669B3ECFDFBQ35839919-A6A26EF8-BEA8-4433-B9D5-7A0645BC8949Q36793042-69E3BB1A-4346-4FD5-9C0F-97B904C9EB07Q39984740-6EC93D7C-D49D-4CA7-B855-656F04FE6DC2Q40961604-E980E357-BBF5-4563-A13A-D4108FCF2848Q41049655-0B502943-13A3-4814-8FE4-64BA36A8198EQ43962549-B7980BDE-CE53-4091-873A-F314077786F4Q46194259-AFCC8F2B-4266-4D86-BDEE-4B3890D788D9Q48193333-CA56EA0B-9EA4-484C-914C-7715337677E2Q51767482-349D398A-98B9-4177-8312-2E9912916E33Q51962067-44DC8362-6074-4C96-BBBB-0EBDB7D71AC0Q52864043-54FC0DE0-4339-4A6B-B4C4-6791C8CB8F38Q52882005-E0BB79FD-EC75-4AD6-AE9E-794C3FB53D92Q53046235-E4120A65-8847-4BFA-A1EB-10D6FAC7FF67Q54471970-8EA93D5F-B994-4010-92FA-8133BE0F7A4AQ54654736-4F9361C5-28F9-4D73-860C-9B5B985C995AQ56380406-BC25D2A3-1198-462B-93BA-3F1D2EF2D193Q57557766-7DEF6BAF-E02B-4BFB-A29F-2882636D6410Q57557794-6C5302E1-F769-4962-9D74-F74EE937174CQ57825068-5EF324B3-FAE8-4B9E-B0F9-CACEE4C7A968Q61454105-E773C708-7ED3-408E-8BC3-D337344D9A25Q61755127-77C87B64-4B5A-4762-B14C-21062E17D584Q61852117-681C749F-341F-489B-8419-E1AE99211ACAQ61866014-8CF63FA8-A8B8-4D2E-AE6A-64C02AD1C1D1Q62772239-B7B2D6A6-6E7C-4EB6-AEC7-E6454DE0AE01Q66829431-C3DA5845-B2B2-4600-B7A6-E91024C321F7Q66829434-6FAAEBB3-12FD-4E8B-B66D-FFBE157384D9Q73943201-E0561843-DC5B-46CD-8E2D-919764A2AB7BQ79976214-83A967B2-4A8E-422E-B1D6-D638B724DE3DQ80251496-5ED8A6D9-218A-478D-BE28-69E12C0A4580Q82035491-C4CCC1FA-BE7E-43DB-B414-897A9FA62037Q82616306-7147E625-386A-4724-A0F9-CA332291CCE8Q83177126-3D61DC3E-7E90-45F9-88FC-8A5309225CF4Q83568445-CC9647AE-AF96-4811-A730-015E4D7E0506Q83787514-44E2F271-16B4-40D9-B271-CD572FDAEA8DQ83836472-CB1A800A-B1F2-45C2-8DBE-1E694DA0DFB2Q83888302-69784122-37C3-466E-8178-9181726DC5B3
P50
description
Czech geneticist and gynecologist
@en
dokter
@id
gynaecoloog
@nl
český genetik a gynekolog
@cs
name
Pavel Calda
@ast
Pavel Calda
@cs
Pavel Calda
@en
Pavel Calda
@es
Pavel Calda
@fr
Pavel Calda
@it
Pavel Calda
@nl
Pavel Calda
@sl
type
label
Pavel Calda
@ast
Pavel Calda
@cs
Pavel Calda
@en
Pavel Calda
@es
Pavel Calda
@fr
Pavel Calda
@it
Pavel Calda
@nl
Pavel Calda
@sl
prefLabel
Pavel Calda
@ast
Pavel Calda
@cs
Pavel Calda
@en
Pavel Calda
@es
Pavel Calda
@fr
Pavel Calda
@it
Pavel Calda
@nl
Pavel Calda
@sl
P106
P214
P1053
C-9171-2017
P1153
7004114586
P19
P21
P213
0000 0000 5835 7724
P214
P31
P373
Pavel Calda
P3829
P496
0000-0002-2903-5026
P569
1957-01-07T00:00:00Z
P691
mzk2006323882
P735
P7859
viaf-84657093